JNCE - Jounce Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - JNCE (1640455)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
14 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-09-15
JNCEDuncan Barbara GayleDirS - Sale+OE$10.00-10,0000-100%-$100,000
2020-09-01
JNCEDrapkin Kimberlee CCFO, TreasurerS - Sale$8.06-7,20061,708-10%-$58,032
M
2020-08-14
JNCEDrapkin Kimberlee CCFO, TreasurerS - Sale$4.71-2,18268,908-3%-$10,276
M
2020-08-14
JNCETrehu ElizabethChief Medical OfficerS - Sale$4.71-2,18276,633-3%-$10,276
M
2020-08-14
JNCECole Hugh MChief Business OfficerS - Sale$4.71-2,18261,408-3%-$10,276
2020-01-07
JNCEDrapkin Kimberlee CCFO, TreasurerS - Sale$7.78-2,62444,390-6%-$20,415
2020-01-07
JNCETrehu ElizabethChief Medical OfficerS - Sale$7.78-2,62456,565-4%-$20,415
2020-01-07
JNCEMurray Richard /ca/CEO, PresS - Sale$7.78-7,15087,360-8%-$55,627
2020-01-07
JNCECole Hugh MChief Business OfficerS - Sale$7.78-2,62433,590-7%-$20,415
2020-01-06
JNCEHiggons John DuncanDirS - Sale$8.11-1,50012,013-11%-$12,165
D
2019-12-23
JNCEMurray Richard /ca/CEO, PresS - Sale+OE$8.37-40,00094,510-30%-$334,800
M
2019-08-14
JNCECole Hugh MChief Business OfficerS - Sale$3.99-2,33636,214-6%-$9,330
M
2019-08-14
JNCETrehu ElizabethChief Medical OfficerS - Sale$3.99-2,33659,189-4%-$9,330
M
2019-08-14
JNCEDrapkin Kimberlee CCFO, TreasurerS - Sale$3.99-2,33647,014-5%-$9,330
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top